These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9095204)

  • 21. The treatment of metastatic uveal melanoma.
    Pyrhönen S
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S27-30. PubMed ID: 9849406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
    Bagger M; Smidt-Nielsen I; Andersen MK; Jensen PK; Heegaard S; Andersen KK; Friis S; Kiilgaard JF
    Ophthalmology; 2018 Dec; 125(12):1969-1976. PubMed ID: 29705056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
    Shields CL; Furuta M; Thangappan A; Nagori S; Mashayekhi A; Lally DR; Kelly CC; Rudich DS; Nagori AV; Wakade OA; Mehta S; Forte L; Long A; Dellacava EF; Kaplan B; Shields JA
    Arch Ophthalmol; 2009 Aug; 127(8):989-98. PubMed ID: 19667335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis and treatment of disseminated uveal melanoma.
    Kath R; Hayungs J; Bornfeld N; Sauerwein W; Höffken K; Seeber S
    Cancer; 1993 Oct; 72(7):2219-23. PubMed ID: 7848381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.
    Augsburger JJ; Corrêa ZM; Trichopoulos N
    Arq Bras Oftalmol; 2013; 76(2):72-9. PubMed ID: 23828465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveal melanoma in teenagers and children. A report of 40 cases.
    Shields CL; Shields JA; Milite J; De Potter P; Sabbagh R; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1662-6. PubMed ID: 1800926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma.
    Glynn RJ; Seddon JM; Gragoudas ES; Egan KM; Hart LJ
    Ophthalmology; 1989 Oct; 96(10):1566-73. PubMed ID: 2685710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal Melanoma UK National Guidelines.
    Nathan P; Cohen V; Coupland S; Curtis K; Damato B; Evans J; Fenwick S; Kirkpatrick L; Li O; Marshall E; McGuirk K; Ottensmeier C; Pearce N; Salvi S; Stedman B; Szlosarek P; Turnbull N;
    Eur J Cancer; 2015 Nov; 51(16):2404-12. PubMed ID: 26278648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas.
    Gragoudas ES; Seddon JM; Egan KM; Polivogianis L; Hsieh CC; Goitein M; Verhey L; Munzenrider J; Austin-Seymour M; Urie M
    Ophthalmology; 1986 May; 93(5):675-80. PubMed ID: 3014416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protracted survival after resection of metastatic uveal melanoma.
    Aoyama T; Mastrangelo MJ; Berd D; Nathan FE; Shields CL; Shields JA; Rosato EL; Rosato FE; Sato T
    Cancer; 2000 Oct; 89(7):1561-8. PubMed ID: 11013372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic options in metastatic uveal melanoma.
    Mariani P; Servois V; Piperno-Neumann S
    Dev Ophthalmol; 2012; 49():166-181. PubMed ID: 22042020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature].
    Terheyden P; Kämpgen E; Rünger TM; Bröcker EB; Becker JC
    Hautarzt; 1998 Oct; 49(10):770-3. PubMed ID: 9857252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival from uveal melanoma in Western Australia 1981-2005.
    Chew AL; Spilsbury K; Isaacs TW
    Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.